FDA Approved: HUMALOG MIX75/25 — Supplemental Application (Eli Lilly and Company)

View source ↗

Summary

FDA approved a supplemental application for HUMALOG MIX75/25 (insulin lispro) submitted by Eli Lilly and Company.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus
• Type 2 Diabetes Mellitus

Drugs mentioned

• Humalog Mix75/25 (Insulin lispro)

Snippet

SUPPL AP for HUMALOG MIX75/25 (INSULIN LISPRO)